Extract
Arrhythmia Research Technology, Inc. Announces Research Agreement and Participation in National Institutes of Health Investigation.
FITCHBURG, Mass. -- Arrhythmia Research Technology, Inc. (the "Company" or "ART") (AMEX: HRT) is pleased to announce that it has entered into a Research Agreement with the University of Rochester, Rochester, New York, to participate in a National Institutes for Health ("NIH") funded investigation into "Risk Stratification in MADITT ...
See the full content of this document
Sponsored links
